Net profit of Astrazeneca Pharma India rose 95.25% to Rs 30.85 crore in the quarter ended December 2024 as against Rs 15.80 crore during the previous quarter ended December 2023. Sales rose 43.98% to Rs 440.29 crore in the quarter ended December 2024 as against Rs 305.79 crore during the previous quarter ended December 2023.
| Particulars | Quarter Ended |
| Dec. 2024 | Dec. 2023 | % Var. |
| Sales | 440.29 | 305.79 | 44 |
| OPM % | 17.49 | 4.92 | - |
| PBDT | 84.64 | 24.10 | 251 |
| PBT | 75.57 | 20.40 | 270 |
| NP | 30.85 | 15.80 | 95 |